Search

Displaying results 9301 - 9310 of 10000 in total
  1. Drug

    Edicotinib

    go.drugbank.com/drugs/DB12504
    Investigational

    JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.

  2. Drug

    AZD-9056

    go.drugbank.com/drugs/DB12594
    Investigational

    AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.

  3. Drug

    Malic acid

    go.drugbank.com/drugs/DB12751
    Investigational

    Malic acid has been used in trials studying the treatment of Xerostomia, Depression, and Hypertension.

    Mixtures: AMINOPLASMAL-5% E INFUSION, AMINOPLASMAL-10% E INFUSION
  4. Drug

    Lafutidine

    go.drugbank.com/drugs/DB12770
    Investigational

    Lafutidine has been investigated in Peptic Ulcer, Community-acquired Pneumonia, and Gastroesophageal Reflux Disease (GERD).

  5. Drug

    Palomid 529

    go.drugbank.com/drugs/DB12812
    Investigational

    Palomid 529 has been used in trials studying the treatment of Age-Related Macular Degeneration.

  6. Drug

    UK-500001

    go.drugbank.com/drugs/DB12837
    Investigational

    UK-500,001 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  7. Drug

    Fiacitabine

    go.drugbank.com/drugs/DB12901
    Investigational

    Fiacitabine has been used in trials studying the treatment of HIV Infections and Cytomegalovirus Infections.

  8. Drug

    4-isothioureidobutyronitrile

    go.drugbank.com/drugs/DB13010
    Investigational

    Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer.

  9. Drug

    Polydioxanone

    go.drugbank.com/drugs/DB14832
    Investigational

    Polydioxanone is under investigation in clinical trial NCT00998907 (PDS*Plus and Wound Infections After Laparotomy).

  10. Drug

    Tarloxotinib

    go.drugbank.com/drugs/DB14944
    Investigational

    Tarloxotinib is under investigation in clinical trial NCT03743350 (NSCLC Exon 20 or HER2-activating Mutations).